- Even is an Indian startup founded in 2021 that aims to change a model in which hospital profits grow as tests or admissions increase. The company builds its own hospitals, pays doctors fixed salaries, and said it can pay bonuses based on patient recovery outcomes rather than the number of tests or surgeries.
- In a Series B round led by Khosla Ventures, it raised $50 million, and according to the company, its valuation is $300 million. Cumulative investment exceeds $120 million.
- The company said that the unplanned readmission rate at its own hospitals is below 1%, lower than the industry benchmark of 8 to 15%, and that patient length of stay is 40% shorter. These are figures Even presented, and the source contains no verification from an independent body.
- According to filings submitted to regulators, its net loss for fiscal year 2025 was about 902 million (about $9.5 million), and revenue was about 272 million (about $2.86 million). Reports from the Indian startup outlet Entrackr said the company laid off about 350 people in August.
O: This suits an insurance practitioner worried about the billing structure of Indian hospitals, who wants to compare Even's fixed salary and recovery-outcome bonus design side by side with their company's pay standards.
X: The readmission rate below 1% and the hospital stay reduction of 40% are figures the company announced, with no independent verification, so it is right not to treat them as confirmed results until outside data appears.